Autonomic Technologies Taps Thoratec Alumni For Leadership Roles
This article was originally published in Clinica
Executive Summary
Autonomic Technologies Inc., the developer of the CE-marked Pulsante microstimulator to treat cluster headaches, has appointed Niamh Pellegrini president and CEO and Gerhard Burbach chairman. Both Pellegrini and Burbach was previously with Thoratec, the specialist in implantable heart assist devices; Thoratec was acquired by St Jude Medical in 2015. Pellegrini was formerly president, North America, at Thoratec. She replaces Ben Pless, who stepped down from in December 2015 and is now an industry consultant. Burbach was the former CEO of Thoratec. The appointments come as Redwood, California-based ATI seeks to expand EU commercialization of Pulsante, which stimulates the sphenopalatine ganglion, and speed up its US clinical trial. The company set up its European headquarters in Germany last year.